WELL Health Technologies Corp. (FRA:W7V)

WELL Health Technologies Statistics

Total Valuation

FRA:W7V has a market cap or net worth of EUR 603.37 million. The enterprise value is 1.03 billion.

Market Cap	603.37M
Enterprise Value	1.03B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	253.88M
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	22.58%
Owned by Institutions (%)	5.76%
Float	196.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.76
PS Ratio	0.79
PB Ratio	0.99
P/TBV Ratio	n/a
P/FCF Ratio	14.17
P/OCF Ratio	8.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.62, with an EV/FCF ratio of 24.26.

EV / Earnings	-76.02
EV / Sales	1.34
EV / EBITDA	11.62
EV / EBIT	32.41
EV / FCF	24.26

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.63.

Current Ratio	0.92
Quick Ratio	0.81
Debt / Equity	0.63
Debt / EBITDA	4.24
Debt / FCF	9.05
Interest Coverage	1.12

Financial Efficiency

Return on equity (ROE) is -3.07% and return on invested capital (ROIC) is 2.38%.

Return on Equity (ROE)	-3.07%
Return on Assets (ROA)	1.93%
Return on Invested Capital (ROIC)	2.38%
Return on Capital Employed (ROCE)	3.39%
Revenue Per Employee	507,610
Profits Per Employee	-9,018
Employee Count	1,507
Asset Turnover	0.69
Inventory Turnover	349.22

Taxes

In the past 12 months, FRA:W7V has paid 4.18 million in taxes.

Income Tax	4.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.61%
50-Day Moving Average	2.88
200-Day Moving Average	2.83
Relative Strength Index (RSI)	32.77
Average Volume (20 Days)	48

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:W7V had revenue of EUR 764.97 million and -13.59 million in losses. Loss per share was -0.05.

Revenue	764.97M
Gross Profit	321.03M
Operating Income	34.20M
Pretax Income	-13.80M
Net Income	-13.59M
EBITDA	80.76M
EBIT	34.20M
Loss Per Share	-0.05

Balance Sheet

The company has 50.51 million in cash and 385.21 million in debt, giving a net cash position of -334.70 million.

Cash & Cash Equivalents	50.51M
Total Debt	385.21M
Net Cash	-334.70M
Net Cash Per Share	n/a
Equity (Book Value)	607.89M
Book Value Per Share	2.04
Working Capital	-17.11M

Cash Flow

In the last 12 months, operating cash flow was 71.59 million and capital expenditures -29.02 million, giving a free cash flow of 42.57 million.

Operating Cash Flow	71.59M
Capital Expenditures	-29.02M
Free Cash Flow	42.57M
FCF Per Share	n/a

Margins

Gross margin is 41.97%, with operating and profit margins of 4.47% and -1.78%.

Gross Margin	41.97%
Operating Margin	4.47%
Pretax Margin	-1.80%
Profit Margin	-1.78%
EBITDA Margin	10.56%
EBIT Margin	4.47%
FCF Margin	5.57%

Dividends & Yields

FRA:W7V does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-2.25%
FCF Yield	7.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:W7V has an Altman Z-Score of 1.39 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.39
Piotroski F-Score	5